Galata Acquisition Corporation (NASDAQ:GLTA) announced this morning that it secured shareholder approval for its combination with e-mobility company Marti at a shareholder vote July 6.
The parties expect to close the transaction July 10 and the combined company’s shares and warrants are set to begin trading on the NYSE American the following day under the symbols “MRT” and “MRTW”, respectively.
Galata has not yet released redemption figures for the vote and the SPAC had about $146.6 million in its trust going into the special meeting. It opened above its redemption rate of $10.46 on its July 5 redemption deadline, but took a plunge to $9.74 by close.
The two sides prepared for some level of redemptions, however, having waived the deal’s $50 million minimum cash condition in a May amendment. The transaction originally included $57.5 million in convertible note PIPE commitments from sponsor affiliates and outside investors. But, as a part of the May deal tweaks, investors representing $35.5 million of this amount had the lock-up provisions of their commitment removed.
Galata inked its $532 million business combination with Marti in August 2022. Istanbul, Turkey-based Marti operates a fleet of over 46,000 e-mopeds, e-bikes, and e-scooters, serviced by proprietary software systems and IoT infrastructure.
In May, Marti announced it had grown net revenue 84% in the fourth quarter of 2022 to $6.3 million albeit with -$3.9 million in adjusted EBITDA over this time. It also introduced a pilot for a new carpooling service, but continues to have sensitivity in its dollar-denominated financials to rising inflation with the Turkish lira.
ADVISORS
- B. Riley Securities is acting as capital markets advisor and placement agent to Galata.
- MZ Group is serving as an investor relations advisor to Marti.
- Latham & Watkins LLP is acting as legal counsel to Marti.
- Willkie Farr & Gallagher LLP is acting as legal counsel to Galata.
- White & Case LLP is acting as legal counsel to B. Riley Securities.
Ribbon (NASDAQ:RIBB) has entered into a definitive agreement to combine with Japanese biotech firm DRC Medicine at a pro forma equity value of $422 million. Tokyo-based DRC Medicine manufactures reusable anti-bacterial and anti-allergen wearables and aims to go deeper into the medical device and pharmaceutical space. Transaction Overview Ribbon is expected to provide $50.4 million...
In June 2025, the SPAC market was marked by a notable rise in meeting delays, with adjournments and postponements playing a central role in extension activity, as sponsors navigated a more cautious market environment. Still, several SPACs secured shareholder approvals, and seven business combinations were completed during the month. At the same time, IPO issuance...
An In-Depth Look at SPAC Activity Through the Second Quarter & First Half 2025 Below is a summary of the first half of 2025 SPAC market. If you’d like a pdf copy, you can access the link HERE. Q2 kicked off in chaos. President Trump’s shifting and often contradictory tariff announcements sent markets reeling, driving...
At the SPAC of Dawn The market is set to be showered with new SPACs today as three more SPACs priced their IPOs overnight, bringing 2025’s total to 66, already surpassing the full-year total of 2024. After hours, Ribbon (NASDAQ:RIBB) also added a new SPAC deal to June’s tally just under the wire, bringing the...
NMP Acquisition Corp. (NASDAQ:NMPAU) announced the pricing of its $100 million IPO and its units are expected to begin trading on the Nasdaq under the symbol “NMPAU”, Tuesday, July 1, 2025. The new SPAC plans to combine with a target company that has a resilient business model with potential to scale up revenue. NMP’s management...